ARCHIVES

Professional Societies: ASCO opposes FDA On Stem Cell Transplant Regs

This article is from The Cancer Letter archive.

Vol. 23 No. 19 | May 16, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989

In Brief: Healy Names President, CEO of Red Cross; AMA Supports annual Mammograms for 40+

July 16, 1999

DCPC BSC Committee Endorses Three Research Concepts

April 17, 1987

New CREG Announcements Made By NCI

October 3, 1975

In Brief: Ames, Rowley, Win National Science Medals; New Building Planned for Pittsburgh Center

January 8, 1999

NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year

January 11, 1991